While there has been significant progress in the prevention of new HIV infections, transmission of HIV continues. Clearly, more needs to be done to reduce the rate of new infections through such approaches as increased HIV testing, behavioral interventions and the use of pre-exposure prophylaxis (PrEP). However, many clinicians are not fully equipped to guide their patients through the complex issues associated with HIV prevention. This situation results in patients not receiving optimal preventative care as described in national guidelines and to an increased number of people becoming infected with HIV who might otherwise not be infected.
This educational program has been designed to address these challenges. These 1-2 hour live presentations by national HIV thought leaders include case studies that allow participants to see how the issues discussed can be applied to real-life situations, and participants will be encouraged to ask questions and interact with the speakers to keep the programs lively and engaging. The aim of this program is to educate clinicians who work with various patient populations - especially high-risk patients - about the theoretical framework, latest findings and ongoing research in this field, and to review the professional guidelines in this area. In addition, this program will educate clinicians with strategies to provide improved prevention services to patients, which is expected to help reduce the number of new HIV infections.
This activity is intended for physicians, physician assistants, advanced practice nurses, and other health care professionals involved in the treatment and management of patients with HIV infection.
Upon completion of the program, participants should be able to:
Review the need for strategies to reduce the risk of new infections with HIV in various populations;
Explain the rationale behind various behavioral and medical prevention strategies, including how research findings on these approaches can be applied to clinical practice;
Discuss ongoing research on the use of vaccines, pre-exposure prophylaxis, post-exposure prophylaxis, and other prevention strategies in various populations;
|
Calvin J. Cohen, MD, MS |
Robert M. Grant, MD, MPH |
|
John Bartlett, MD |
Trevor Hawkins, MD |
|
Edwin DeJesus, MD |
Charles Hicks, MD |
|
Richard A. Elion, MD |
David Wohl, MD |
|
Ian Frank, MD |
Andrew Zolopa, MD |
| Judith Feinberg, MD Professor and Director of the AIDS Clinical Trials Unit, Associate Chair for Faculty Development, Infectious Diseases Division, Internal Medicine, University of Cincinnati College of Medicine Cincinnati, Ohio |
|
Date |
Date |
Date |
|
Date |
Date |
Date |
|
Date |
Date |
Date |
|
Date |
Date |
Date |
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Postgraduate Institute for Medicine and ViralEd, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by the Postgraduate Institute for Medicine for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Supported by an unrestricted educational grant from Gilead Sciences

